KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Operating Expenses (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 11 years of Other Operating Expenses data on record, last reported at $2.3 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 118.3% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $8.0 million, down 29.09%, while the annual FY2024 figure was -$12000.0, 92.55% up from the prior year.
  • Other Operating Expenses reached $2.3 million in Q3 2025 per IONS's latest filing, down from $4.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $756.8 million in Q4 2022 and bottomed at $1.1 million in Q3 2024.
  • Average Other Operating Expenses over 5 years is $74.5 million, with a median of $3.0 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: surged 18417.07% in 2021, then crashed 99.6% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $610.9 million in 2021, then rose by 23.89% to $756.8 million in 2022, then plummeted by 99.6% to $3.1 million in 2023, then increased by 25.08% to $3.8 million in 2024, then crashed by 38.96% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $2.3 million in Q3 2025, $4.2 million in Q2 2025, and $1.5 million in Q1 2025.